IntegraGen SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IntegraGen SA with three other
companies in this sector in France:
sales of 6.52 million Euro [US$7.55 million]
Ose Immunotherapeutics SA
(6.68 million Euro [US$7.73 million]
(6.86 million Euro [US$7.94 million]
of which 100%
was Therapeutic Drugs).
IntegraGen SA reported sales of 6.25 million Euro (US$7.23 million)
December of 2017.
increase of 3.7%
versus 2016, when the company's sales were 6.02 million Euro.